Format

Send to

Choose Destination
Iran J Allergy Asthma Immunol. 2016 Jun;15(3):251-6.

Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.

Author information

1
Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2
Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3
Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran.
4
Multiple Sclerosis and Neuroimmunology Research Center, Isfahan, Iran.
5
Department of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
6
Department of Radiology, School of Medicine, Najafabad University of Medical Sciences, Isfahan, Iran.

Abstract

Multiple sclerosis (MS) is a complex, demyelinating disease of the central nervous system (CNS) with variable phenotypic presentations, while Guillain-Barre Syndrome (GBS) is the prototypic acute inflammatory disorder that affects the peripheral nervous system. Myasthenia gravis (MG) is a T cell dependent and antibody mediated autoimmune disease. Although it has been shown that complement plays a critical role in the pathogenesis of MS, GBS, and MG, the role of mannose-binding lectin (MBL) as a biomarker of immunopathogensis of these diseases and also its association with the severity of them have been poorly investigated. Therefore, in this study we aimed to measure plasma levels of MBL in patients with MS, GBS, and MG. In a case-control study, plasma was obtained from healthy controls (n=100) and also patients with MS (n=120), GBS (n=30), and MG (n=30). Plasma level measurement of MBL was performed using enzyme-linked immunosorbent assay (ELISA). The mean serum level of MBL was significantly different between groups of patients and healthy controls (p<0.001). We also found a positive correlation between plasma levels of MBL and severity scores of MS, MG, and GBS patients including: expanded disability status scale (EDSS) (r=+0.60 and p=<0.001), quantitative myasthenia gravis score (QMGS) (r=+0.56 and p=0.01), and GBS disability scale (GDS) (r=+0.37 and p=0.04). Taken together, our findings suggest that complement activation mediated by MBL contributes to the pathogenesis and also severity of MS, MG, and GBS. However, because the lectin pathway can be involved in several phases of the immune response, further evidence will be required to elucidate the underlying mechanism.

KEYWORDS:

Autoimmunity; Complement system proteins; Guillain-Barre syndrome; Mannose-binding lectin; Multiple sclerosis; Myasthenia gravis

PMID:
27424141
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Tehran University of Medical Sciences, The Center for Electronic Resources Provision & Journals Development
Loading ...
Support Center